Action CENBF CEN BIOTECH, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues CEN Biotech, Inc.

Actions

CENBF

CA15130L1040

Marché Fermé - OTC Markets
Autres places de cotation
 17:49:14 29/04/2024 		Varia. 5j. Varia. 1 janv.
0,00738 USD +138,06 % Graphique intraday de CEN Biotech, Inc. +138,71 % +146,67 %
2023 CEN Biotech, Inc. annonce la démission de Lawrence Lehoux en tant que membre du conseil d'administration et directeur de la technologie CI
2022 CEN Biotech, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2022 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CEN BIOTECH INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS
CEN Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
CEN Biotech, Inc. announced that it has received $0.07 million in funding from 1800 Diagonal Lending, LLC
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS
CEN Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CEN BIOTECH INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
CEN Biotech, Inc. Announces Changes to Its Board
CEN BIOTECH INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
CEN Biotech, Inc. Announces Management Changes
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action CENBF
  4. Actualités CEN Biotech, Inc.
  5. Autres langues